T2 Biosystems

^{Priced, Nasdaq: TTOO}

Developing diagnostic tests to screen for sepsis and impaired hemostasis.

Industry: Health Care

First Day Return: +30.2%

TTOO

Developing diagnostic tests to screen for sepsis and impaired hemostasis.

IPO News for T2 Biosystems

US IPO Pricing Recap: 7 IPOs see heavy discounts and positive trading 08/08/14
T2 Biosystems prices upsized IPO at $11, well below the range 08/07/14
11 US IPOs planned for the week of Aug 4 08/04/14

IPO Data
IPO Date	08/06/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$57
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.t2biosystems.com
Headquarters	Lexington, MA, United States
Founded	2006
Employees at IPO	68

IPO News for T2 Biosystems

US IPO Pricing Recap: 7 IPOs see heavy discounts and positive trading 08/08/14
T2 Biosystems prices upsized IPO at $11, well below the range 08/07/14
11 US IPOs planned for the week of Aug 4 08/04/14

T2 Biosystems (TTOO) Performance